Annual Net Margin
-486.59%
+2948.82%+85.84%
December 31, 2023
Summary
- As of March 3, 2025, FDMT annual net profit margin is -486.59%, with the most recent change of +2948.82% (+85.84%) on December 31, 2023.
- During the last 3 years, FDMT annual net margin has fallen by -70.10% (-16.83%).
- FDMT annual net margin is now -619.91% below its all-time high of -67.59%, reached on December 31, 2018.
Performance
FDMT Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-1.46 M%
-762.37 K%-109.06%
September 30, 2024
Summary
- As of March 3, 2025, FDMT quarterly net profit margin is -1.46 million%, with the most recent change of -762.37 thousand% (-109.06%) on September 30, 2024.
- Over the past year, FDMT quarterly net margin has dropped by -1.46 million% (-2879004.28%).
- FDMT quarterly net margin is now -2879004.28% below its all-time high of -50.76%, reached on September 30, 2023.
Performance
FDMT Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
FDMT Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +85.8% | -10000.0% |
| 3 y3 years | -16.8% | -10000.0% |
| 5 y5 years | -619.9% | -10000.0% |
FDMT Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.1% | +85.8% | <-9999.0% | at low |
| 5 y | 5-year | -23.1% | +85.8% | <-9999.0% | at low |
| alltime | all time | -619.9% | +85.8% | <-9999.0% | at low |
4D Molecular Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1.46 M%(+109.1%) |
| Jun 2024 | - | -699.06 K%(+504.1%) |
| Mar 2024 | - | -115.72 K%(>+9900.0%) |
| Dec 2023 | -486.59%(-85.8%) | - |
| Sep 2023 | - | -50.76%(-99.6%) |
| Jun 2023 | - | -12.39 K%(+28.7%) |
| Mar 2023 | - | -9624.83%(+338.4%) |
| Dec 2022 | -3435.41%(+768.9%) | -2195.59%(-57.3%) |
| Sep 2022 | - | -5138.20%(-70.4%) |
| Jun 2022 | - | -17.34 K%(+702.4%) |
| Mar 2022 | - | -2160.62%(-92.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -395.37%(-5.1%) | -27.26 K%(+1574.7%) |
| Sep 2021 | - | -1628.04%(+3027.8%) |
| Jun 2021 | - | -52.05%(-93.7%) |
| Mar 2021 | - | -820.30%(+677.2%) |
| Dec 2020 | -416.49%(-41.0%) | - |
| Sep 2020 | - | -105.55%(-74.7%) |
| Jun 2020 | - | -417.09%(+12.0%) |
| Mar 2020 | - | -372.28%(-53.1%) |
| Dec 2019 | -705.78%(+944.2%) | -793.84%(-74.3%) |
| Sep 2019 | - | -3087.96% |
| Dec 2018 | -67.59%(-65.1%) | - |
| Dec 2017 | -193.83% | - |
FAQ
- What is 4D Molecular Therapeutics annual net profit margin?
- What is the all time high annual net margin for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual net margin year-on-year change?
- What is 4D Molecular Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly net margin year-on-year change?
What is 4D Molecular Therapeutics annual net profit margin?
The current annual net margin of FDMT is -486.59%
What is the all time high annual net margin for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual net profit margin is -67.59%
What is 4D Molecular Therapeutics annual net margin year-on-year change?
Over the past year, FDMT annual net profit margin has changed by +2948.82% (+85.84%)
What is 4D Molecular Therapeutics quarterly net profit margin?
The current quarterly net margin of FDMT is -1.46 M%
What is the all time high quarterly net margin for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly net profit margin is -50.76%
What is 4D Molecular Therapeutics quarterly net margin year-on-year change?
Over the past year, FDMT quarterly net profit margin has changed by -1.46 M% (-2879004.28%)